News Agency
The Times Real Estate

QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours

  • Written by PR Newswire
  • STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary Medicine for the treatment of non-metastatic mast cell tumours (MCT) in dogs, making it the first pharmaceutical treatment available for all grades of canine non-metastatic MCT[1]
  • FDA approval follows the early 2020 marketing...

Read more: QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours

Overcoming Dental Anxiety: A Guide to Comfortable Implant Procedures in Perth

Dental anxiety is a prevalent issue that keeps numerous patients away from their much-needed oral care treatment. This anxiety can be more extreme in the case of more involved procedures like dental implants. Nevertheless, due to advances in modern dentistry... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion